Business Wire

DAHUA-THERMAL-SOLUTION

2.3.2020 14:47:05 CET | Business Wire | Press release

Share
Dahua Thermal Solution Supports Epidemic Prevention and Control

The year 2020 is bound to be a special year with the outbreak of coronavirus disease 2019 (COVID-19) globally. Until today, the highly contagious disease has taken away many lives, especially in China, South Korea, Japan, and some countries in Europe and Middle East.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200302005479/en/

Dahua Technology, a world-leading video-centric smart IoT solution and service provider, has been an early participant in the epidemic prevention and control in Asia, joining the global efforts in combating the virus to minimize the impact on mankind. Since sending its first batch of thermal cameras to the hardest-hit area Wuhan on January 24th , Dahua thermal solution has been deployed in thousands of sites in China, including transportation hubs, commercial complexes, banks, and other places, and some are on the way to multiple countries in Asia.

Hong Kong, a financial capital in Asia, also suffers from the COVID-19 epidemic situation. Dahua Thermal Solution has been applied in some local business complexes, banks, company parks, and other places. To enable a safe and smooth work resumption recently, quite a few major corporations have been using Dahua Thermal Solution in their headquarters to improve their workplace safety, such as Paul Y. Engineering Group Limited. Dahua Thermal Solution measures the body temperature of their employees, handling thousands of staff flow every day. Compare to the traditional way of body temperature measurement – a forehead thermometer, using Dahua Thermal Solution will significantly improve speed and accuracy, meanwhile help reduce cross-infection via non-contact measurement. To measure the temperature of 5,000 people, it will take about 4.2 hours using a forehead thermometer, as it takes at least 3 seconds to measure a person. However, it takes only 30 minutes if you use Dahua Thermal Solution, which measures 3 person per second. It also features a high accuracy of ±0.3℃ .

“Dahua Thermal Solution helped us detect a couple of suspected cases in just a few hours of operation, which we greatly appreciate,” a Hongkong user commented.

Dahua Thermal Solution has been on the front line since the very beginning, helping with the epidemic prevention and control in airports, railway stations, hospitals, schools, and other sites all over Asia. Featuring high accuracy, high efficiency, strong adaptability and easy deployment, Dahua Thermal Solution can also be applied to all kinds of entrances and exits, kitchens and kindergartens.

Link:

ClickThru

Social Media:

https://www.facebook.com/DahuaHQ/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release

- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur

Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release

A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye